What is the UA review and approval process?
• The medical sets are clinically reviewed based on a cyclic review schedule and sets are usually reviewed every 3 years. This schedule is developed by DCDD(Directorate of Combat and Doctrine Development) at AMEDD Center & School, Ft Sam Houston, TX, with input from USAMMA, according to the guidance of AR 40-60 and AR 71-32. • The Combat Developer (DCDD) identifies which sets will be reviewed and when. • A new NSN and a new UAC are assigned when the set is clinically reviewed and the nomenclature of the set should identify the year of the review. • When the set is reviewed by the panel at DCDD (USAMMA participates), the approval process is the responsibility of the Combat Developer. Any submitted DA Form 2028’s recommending set changes are reviewed at this time (reference USAMMA FAQ 3 g). The approval may be immediate or it could take 9-10 months and the approval process may cross over into the next FY. A delay in the approval process can occur if DCDD determines a Form, Fit, and Funct
